Transcutaneous Jaundice Detector

Name: Transcutaneous Jaundice Detector - Amaris Medical Solutions
Price: 1.00 USD
Availability: InStock

$1.00

WhatsApp Order

A Transcutaneous Jaundice Detector (TcB meter) is a Class II medical device that non-invasively estimates serum bilirubin levels in newborns using reflectance spectrophotometry or multi-wavelength optical analysis, providing rapid (1-5 seconds), painless screening for neonatal hyperbilirubinemia. Handheld, battery-operated device measures yellow coloration of subcutaneous tissue at the forehead or sternum, displaying results in mg/dL or µmol/L. Features include digital display, data storage (100-1,000 readings), USB/Bluetooth connectivity, and disposable probe covers for infection control. Correlation with serum bilirubin typically R² >0.9. Primary clinical applications include universal newborn screening before hospital discharge (AAP guidelines), monitoring bilirubin trends in at-risk infants, assessing phototherapy efficacy, and post-discharge follow-up in community settings. Critical safety considerations include mandatory confirmatory serum testing for abnormal values, daily calibration verification, use of disposable probe covers to prevent cross-contamination, avoidance of measurement on phototherapy-exposed skin, and proper technique (site selection, gentle pressure, averaging multiple readings). Essential screening tool in newborn nurseries, NICUs, and community healthcare settings for preventing kernicterus through early detection and management of neonatal jaundice.

Compare

Add to wishlist

Categories: DIAGNOSTIC EQUIPMENT, Diagnostic Kits, OBSTETRICS, GYNECOLOGY AND NEONATAL Tags: Bilirubinometer, Hyperbilirubinemia, Jaundice Meter, Neonatal Bilirubin, Newborn Screening, TcB Meter, Transcutaneous Bilirubinometer, Transcutaneous Jaundice Detector

Description

Transcutaneous Jaundice Detector

PRIMARY CLINICAL & DIAGNOSTIC USES

1. Non-Invasive Neonatal Bilirubin Screening

Primary Use: Provides rapid, painless measurement of bilirubin levels in newborns by measuring the yellow coloration of subcutaneous tissue.
How it helps: For the pediatrician, nurse, or midwife, it transforms jaundice assessment from a subjective visual guess (“does this baby look yellow?”) into an objective, quantifiable measurement in seconds. For the newborn, it means no painful heel sticks for routine screening—simply a gentle probe placed on the skin, eliminating the trauma and crying associated with blood draws for millions of babies every year.

2. Risk Assessment for Severe Hyperbilirubinemia

Primary Use: Identifies infants at risk of developing significant jaundice before hospital discharge, allowing early intervention.
How it helps: For the discharging provider, it provides objective data to determine which babies need a blood test, which need follow-up tomorrow, and which can safely go home with routine care. For the parents and their newborn, it offers protection against the “silent danger” of jaundice—identifying at-risk infants before bilirubin reaches dangerous levels, preventing the devastating and entirely preventable brain damage of kernicterus.

3. Monitoring Bilirubin Trends in At-Risk Infants

Primary Use: Serial transcutaneous measurements track bilirubin progression in infants receiving phototherapy or those with hemolytic conditions.
How it helps: For the NICU team managing a baby under the lights, it allows frequent checks without draining the infant’s blood volume through repeated lab draws. For the fragile infant, particularly preterm babies with tiny blood volumes, every spared heel stick preserves precious red blood cells and reduces the anemia that prolonged NICU stays can cause.

4. Post-Discharge Follow-Up in Community Settings

Primary Use: Portable devices enable home health nurses, midwives, and community healthcare workers to monitor jaundice after early hospital discharge.
How it helps: For the community healthcare provider visiting a newborn at home, it brings hospital-level assessment capability directly to the family’s door. For the new parents navigating the anxiety of early discharge, it means their baby can be monitored for jaundice in the comfort of their own home—catching rising bilirubin early without multiple stressful trips back to the hospital.

5. Phototherapy Efficacy Assessment

Primary Use: Measurements taken before, during, and after phototherapy help evaluate treatment response, guiding decisions on therapy duration.
How it helps: For the neonatologist, serial measurements provide clear evidence of whether the lights are working or if therapy needs to be intensified. For the infant under phototherapy, it means treatment continues only as long as necessary—not a moment longer—reducing separation from parents and allowing them to return to normal feeding and bonding as soon as it’s safe.

6. Maternity Ward and Newborn Nursery Screening

Primary Use: Routine screening of all newborns before discharge implements universal screening protocols recommended by pediatric academies worldwide.
How it helps: For the maternity ward team, it enables efficient, high-volume screening of every baby before they go home, integrating seamlessly into the discharge workflow. For every newborn, regardless of whether they look “yellow” to the naked eye, this universal screening ensures no baby slips through the cracks with undetected jaundice.

7. Emergency Department and Urgent Care Evaluation

Primary Use: Rapid assessment of jaundiced infants presenting to emergency settings helps determine the need for immediate blood testing and potential admission.
How it helps: For the emergency physician seeing a worried parent with a yellow baby, it provides immediate risk stratification—identifying which infants need stat labs and admission versus those who can follow up with their pediatrician. For the anxious parent and their fussy infant, it often means avoiding a long emergency department stay for bloodwork and waiting for results, providing quick answers and peace of mind.

SECONDARY & SUPPORTIVE USES

1. Clinical Research and Epidemiological Studies: For the neonatal researcher, it enables large-scale studies of bilirubin metabolism without subjecting thousands of infants to painful blood draws. For the scientific community, this data advances understanding of jaundice and improves screening protocols worldwide.

2. Telemedicine and Remote Monitoring: For the community hospital without a neonatologist on site, it allows transmission of objective bilirubin measurements for specialist consultation. For the infant born in a smaller hospital, it brings expert assessment to their bedside without the need for transfer to a larger center.

3. Parental Education and Reassurance: For the pediatrician counseling concerned parents, an objective number is far more powerful than “he looks a little yellow.” For the worried mother, seeing the actual measurement and where it falls on the risk curve provides concrete reassurance or clear understanding of why treatment is needed.

4. International Health and Resource-Limited Settings: For the global health worker in a low-resource clinic, a portable, battery-operated device enables jaundice screening where laboratory testing is unavailable. For families in underserved regions, it brings a modern standard of care to communities where kernicterus previously went unchecked.

5. Teaching and Training: For the neonatal nursing instructor, it demonstrates modern, evidence-based jaundice assessment. For the trainee—whether medical student or resident—hands-on experience builds competence in screening and managing one of the most common conditions in newborn medicine.

6. Newborn Transport Services: For the neonatal transport team, it enables continuous monitoring of bilirubin trends during long transfers. For the critically ill infant being moved between facilities, it ensures that rising jaundice is detected and addressed during transport, not discovered upon arrival.

KEY PRODUCT FEATURES

1. BASIC IDENTIFICATION ATTRIBUTES

Product Type: Non-invasive medical device that estimates serum bilirubin level by measuring the yellow color of subcutaneous tissue using reflectance spectrophotometry or multi-wavelength analysis.
Common Names: Transcutaneous Jaundice Detector, Transcutaneous Bilirubinometer, TcB Meter, Bilirubinometer, Jaundice Meter, Transcutaneous Bilirubin Analyzer.
Measurement Principle: Reflectance spectrophotometry or multi-wavelength optical analysis measuring the yellow color of bilirubin in subcutaneous tissue.
Measurement Site: Typically forehead or sternum (over bony prominence to avoid pressure on soft tissue).
Measurement Time: 1-5 seconds per reading.
Display: Digital LCD showing bilirubin value in mg/dL or µmol/L.
Measurement Range: Typically 0-20 mg/dL (0-340 µmol/L).
Accuracy: Correlation with serum bilirubin typically R² >0.9; used as screening tool, not diagnostic replacement.
Calibration: Factory calibrated; some models require periodic calibration verification with provided standard.
Power Source: Rechargeable batteries, replaceable batteries (AA), or AC power.

2. TECHNICAL & PERFORMANCE PROPERTIES

Measurement Technology:
- Reflectance Spectrophotometry: Measures light reflected from skin at wavelengths specific to bilirubin absorption (typically 450-460 nm).
- Multi-Wavelength Analysis: Uses multiple wavelengths to compensate for melanin, hemoglobin, and other interfering pigments.
- Optical Fiber Probe: Delivers light to skin and collects reflected light for analysis.
Correlation with Serum Bilirubin: 0.90-0.95 correlation coefficient (varies by device and population).
Measurement Precision: CV <5-10% for repeated measurements.
Interference Compensation: Algorithms to adjust for skin pigmentation (melanin) and gestational age.
Temperature Stability: Accurate across typical clinical temperature ranges (15-35°C).
Battery Life: 100-500 measurements per charge depending on model and battery type.
Data Storage: Internal memory for 100-1,000 measurements with date/time stamps.
Data Output: USB, Bluetooth, or infrared for data transfer to EMR or PC.
Operating Temperature: 10-40°C (50-104°F).
Operating Humidity: 10-90% non-condensing.

3. PHYSICAL & OPERATIONAL PROPERTIES

Dimensions: 15-20 cm × 5-8 cm × 3-5 cm (handheld).
Weight: 150-400 grams (lightweight, portable).
Housing: Medical-grade ABS plastic; impact-resistant; easy-clean surfaces.
Probe Tip: Optical measurement tip; may have disposable covers to prevent cross-contamination.
Display: Backlit LCD with large numerals; shows measurement value and battery status.
Controls: Minimal buttons (power, measure) for ease of use; some models with menu navigation.
Calibration Cuvette: Provided for daily calibration verification (varies by model).
Storage Case: Protective case for transport and storage.
Power Options: Rechargeable lithium-ion (with charging cradle) or AA batteries.
Certifications: CE marked; FDA cleared; ISO 13485 manufacturing.

4. SAFETY & COMPLIANCE ATTRIBUTES

Regulatory Status: Class II medical device requiring FDA 510(k) clearance; CE marked for IVD use.
Clinical Standards: Meets applicable standards for non-invasive bilirubin measurement devices (CLSI C46-A guidelines).
Optical Safety: Low-intensity light safe for neonatal skin and eyes; no known adverse effects.
Electrical Safety: Compliant with IEC 60601-1 for medical electrical equipment.
Biocompatibility: Probe tip materials meet ISO 10993 for skin contact.
Latex-Free: All patient-contact materials latex-free.
Data Security: Compliant with relevant data protection regulations.
Calibration: Factory calibrated; verification with calibration standard recommended daily.
Infection Control: Disposable probe covers available for single-patient use to prevent cross-contamination.
Quality Management: Manufactured under ISO 13485 certified processes.

5. STORAGE & HANDLING ATTRIBUTES

Storage: Store in a clean, dry environment at room temperature (15-35°C); protect from dust, moisture, and direct sunlight.
Battery Maintenance: Keep batteries charged; rechargeable models should be docked when not in use.
Probe Care: Keep measurement tips clean; use disposable probe covers for each patient; do not scratch the optical surface.
Calibration Verification: Perform daily calibration check using provided standard cuvette; document results.
Cleaning: Wipe exterior with EPA-registered hospital disinfectant; do not immerse; clean probe tip with soft, lint-free cloth.
Disinfection: Use approved disinfectant wipes compatible with device materials.
Inspection: Before each use, check for damage to probe tip, housing, or display; verify calibration status.
Probe Covers: Ensure adequate supply of disposable covers; do not reuse covers between patients.
Data Download: Periodically download stored measurements for documentation and EMR integration.
Expiration: Check expiration date of calibration cuvette; replace as needed.

6. LABORATORY & CLINICAL APPLICATIONS

Primary Application: Non-invasive screening and monitoring of neonatal hyperbilirubinemia.
American Academy of Pediatrics (AAP) Guidelines:
- Universal Screening: All newborns should be assessed for risk of severe hyperbilirubinemia before discharge.
- TcB Screening: Transcutaneous bilirubin measurement is acceptable for screening; values above certain thresholds require confirmatory serum testing.
- Monitoring: Serial TcB measurements can track bilirubin trends in infants receiving phototherapy.
- Discharge Planning: TcB helps determine safe timing of discharge and need for follow-up.
Measurement Protocol:

Select measurement site (forehead or sternum - over bony prominence).
Ensure skin is clean, dry, and free of lotions or ointments.
Apply disposable probe cover (if used).
Place the probe gently against skin; avoid pressing too hard.
Press the measurement button; hold steady for 1-5 seconds.
Read displayed bilirubin value.
Repeat for 2-3 measurements and average for accuracy.

Interpretation:
- Screening Values: Values below age-specific threshold indicate low risk; values above threshold require confirmatory serum bilirubin.
- Phototherapy Thresholds: Compare to hour-specific nomograms (AAP) to determine need for phototherapy.
- Trend Monitoring: Rising values indicate need for closer follow-up or intervention.
Limitations:
- Less accurate in infants >35 weeks gestational age after the first week of life.
- May be affected by skin pigmentation (though modern devices compensate).
- Not reliable in infants receiving phototherapy (bleaches skin).
- Cannot replace serum bilirubin for diagnosis or treatment decisions.

SAFETY HANDLING PRECAUTIONS

1. SAFETY PRECAUTIONS

Confirmatory Testing Required: TcB is a screening tool; abnormal values must be confirmed with serum bilirubin before initiating treatment.
Site Selection: Measure over bony prominence (forehead, sternum) to avoid pressure on soft tissue.
Skin Condition: Ensure skin is clean, dry, and free of lotions, ointments, or meconium.
Phototherapy Interference: Do not measure on skin exposed to phototherapy light; bilirubin is degraded by light, giving falsely low readings.
Probe Covers: Use disposable covers for each patient to prevent cross-contamination.
Calibration: Verify calibration daily; out-of-calibration devices give inaccurate results.
Pressure: Do not press the probe too firmly; excessive pressure may affect readings.
Multiple Readings: Take 2-3 readings and average for best accuracy.
Documentation: Record values in medical record; note use of TcB vs. serum bilirubin.
Training: Operators should be trained on proper technique and interpretation.

2. FIRST AID MEASURES

Device Malfunction: If device fails to measure or displays error, troubleshoot per manual; use alternative method (serum bilirubin).
Probe Tip Damage: If the optical tip scratched or damaged, discontinue use; return for service.
Battery Failure: If battery depleted, use an AC adapter or replace batteries; have a backup device available.
Patient Reaction: No known adverse reactions; if skin irritation occurs, discontinue use and assess.

3. FIRE FIGHTING MEASURES

Flammability: Plastic housing and components are combustible.
Extinguishing Media: For electrical fire, use CO₂ or dry chemical (Class C) extinguisher.
Power Off: Disconnect power if safe to do so.

Transcutaneous Jaundice Detector

Transcutaneous Jaundice Detector

PRIMARY CLINICAL & DIAGNOSTIC USES

1. Non-Invasive Neonatal Bilirubin Screening

Primary Use: Provides rapid, painless measurement of bilirubin levels in newborns by measuring the yellow coloration of subcutaneous tissue.

2. Risk Assessment for Severe Hyperbilirubinemia

Primary Use: Identifies infants at risk of developing significant jaundice before hospital discharge, allowing early intervention.

3. Monitoring Bilirubin Trends in At-Risk Infants

Primary Use: Serial transcutaneous measurements track bilirubin progression in infants receiving phototherapy or those with hemolytic conditions.

4. Post-Discharge Follow-Up in Community Settings

Primary Use: Portable devices enable home health nurses, midwives, and community healthcare workers to monitor jaundice after early hospital discharge.

5. Phototherapy Efficacy Assessment

Primary Use: Measurements taken before, during, and after phototherapy help evaluate treatment response, guiding decisions on therapy duration.

6. Maternity Ward and Newborn Nursery Screening

Primary Use: Routine screening of all newborns before discharge implements universal screening protocols recommended by pediatric academies worldwide.

7. Emergency Department and Urgent Care Evaluation

Primary Use: Rapid assessment of jaundiced infants presenting to emergency settings helps determine the need for immediate blood testing and potential admission.

SECONDARY & SUPPORTIVE USES

5. Teaching and Training: For the neonatal nursing instructor, it demonstrates modern, evidence-based jaundice assessment. For the trainee—whether medical student or resident—hands-on experience builds competence in screening and managing one of the most common conditions in newborn medicine.

1. BASIC IDENTIFICATION ATTRIBUTES

Product Type: Non-invasive medical device that estimates serum bilirubin level by measuring the yellow color of subcutaneous tissue using reflectance spectrophotometry or multi-wavelength analysis.

Common Names: Transcutaneous Jaundice Detector, Transcutaneous Bilirubinometer, TcB Meter, Bilirubinometer, Jaundice Meter, Transcutaneous Bilirubin Analyzer.

Measurement Principle: Reflectance spectrophotometry or multi-wavelength optical analysis measuring the yellow color of bilirubin in subcutaneous tissue.

Measurement Site: Typically forehead or sternum (over bony prominence to avoid pressure on soft tissue).

Measurement Time: 1-5 seconds per reading.

Display: Digital LCD showing bilirubin value in mg/dL or µmol/L.

Measurement Range: Typically 0-20 mg/dL (0-340 µmol/L).

Accuracy: Correlation with serum bilirubin typically R² >0.9; used as screening tool, not diagnostic replacement.

Calibration: Factory calibrated; some models require periodic calibration verification with provided standard.

Power Source: Rechargeable batteries, replaceable batteries (AA), or AC power.

2. TECHNICAL & PERFORMANCE PROPERTIES

Measurement Technology:

Reflectance Spectrophotometry: Measures light reflected from skin at wavelengths specific to bilirubin absorption (typically 450-460 nm).

Multi-Wavelength Analysis: Uses multiple wavelengths to compensate for melanin, hemoglobin, and other interfering pigments.

Optical Fiber Probe: Delivers light to skin and collects reflected light for analysis.

Correlation with Serum Bilirubin: 0.90-0.95 correlation coefficient (varies by device and population).

Measurement Precision: CV <5-10% for repeated measurements.

Interference Compensation: Algorithms to adjust for skin pigmentation (melanin) and gestational age.

Temperature Stability: Accurate across typical clinical temperature ranges (15-35°C).

Battery Life: 100-500 measurements per charge depending on model and battery type.

Data Storage: Internal memory for 100-1,000 measurements with date/time stamps.

Data Output: USB, Bluetooth, or infrared for data transfer to EMR or PC.

Operating Temperature: 10-40°C (50-104°F).

Operating Humidity: 10-90% non-condensing.

3. PHYSICAL & OPERATIONAL PROPERTIES

Dimensions: 15-20 cm × 5-8 cm × 3-5 cm (handheld).

Weight: 150-400 grams (lightweight, portable).

Housing: Medical-grade ABS plastic; impact-resistant; easy-clean surfaces.

Probe Tip: Optical measurement tip; may have disposable covers to prevent cross-contamination.

Display: Backlit LCD with large numerals; shows measurement value and battery status.

Controls: Minimal buttons (power, measure) for ease of use; some models with menu navigation.

Calibration Cuvette: Provided for daily calibration verification (varies by model).

Storage Case: Protective case for transport and storage.

Power Options: Rechargeable lithium-ion (with charging cradle) or AA batteries.

Certifications: CE marked; FDA cleared; ISO 13485 manufacturing.

4. SAFETY & COMPLIANCE ATTRIBUTES

Regulatory Status: Class II medical device requiring FDA 510(k) clearance; CE marked for IVD use.

Clinical Standards: Meets applicable standards for non-invasive bilirubin measurement devices (CLSI C46-A guidelines).

Optical Safety: Low-intensity light safe for neonatal skin and eyes; no known adverse effects.

Electrical Safety: Compliant with IEC 60601-1 for medical electrical equipment.

Biocompatibility: Probe tip materials meet ISO 10993 for skin contact.

Latex-Free: All patient-contact materials latex-free.

Data Security: Compliant with relevant data protection regulations.

Calibration: Factory calibrated; verification with calibration standard recommended daily.

Infection Control: Disposable probe covers available for single-patient use to prevent cross-contamination.

Quality Management: Manufactured under ISO 13485 certified processes.

5. STORAGE & HANDLING ATTRIBUTES

Storage: Store in a clean, dry environment at room temperature (15-35°C); protect from dust, moisture, and direct sunlight.

Battery Maintenance: Keep batteries charged; rechargeable models should be docked when not in use.

Probe Care: Keep measurement tips clean; use disposable probe covers for each patient; do not scratch the optical surface.

Calibration Verification: Perform daily calibration check using provided standard cuvette; document results.

Cleaning: Wipe exterior with EPA-registered hospital disinfectant; do not immerse; clean probe tip with soft, lint-free cloth.

Disinfection: Use approved disinfectant wipes compatible with device materials.

Inspection: Before each use, check for damage to probe tip, housing, or display; verify calibration status.

Probe Covers: Ensure adequate supply of disposable covers; do not reuse covers between patients.

Data Download: Periodically download stored measurements for documentation and EMR integration.

Expiration: Check expiration date of calibration cuvette; replace as needed.

6. LABORATORY & CLINICAL APPLICATIONS

Primary Application: Non-invasive screening and monitoring of neonatal hyperbilirubinemia.

American Academy of Pediatrics (AAP) Guidelines: